Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera vs Avandia in T2DM poorly controlled on Metformin/Sulfonylurea
NCT00150410Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Biologic
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of insulin human in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Pfizer. Primary endpoint: Glycosylated hemoglobin. Started Jan 2003; status: completed.
02
Drugs
insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00150410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150410.